Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2024 Aug 15;31(9-10):528. doi: 10.1038/s41434-024-00473-x

Correction: Alternative oxidase encoded by sequence-optimized and chemically-modified RNA transfected into mammalian cells is catalytically active

Luca Giordano 1,2,3,8,, Manish K Aneja 4, Natascha Sommer 3, Nasim Alebrahimdehkordi 3, Alireza Seraji 3, Norbert Weissmann 3, Carsten Rudolph 4,5, Christian Plank 4,6, Howard T Jacobs 1,2, Marten Szibor 1,2,7,
PMCID: PMC11399076  PMID: 39147867

Correction to: Gene Therapy 10.1038/s41434-021-00235-z, published online 04 March 2021

We have become aware of an error in Supplementary Fig. 2 of this paper. Two loading controls for a western blot (ɑ-Tubulin and GAPDH) were immunolabeled on the same membrane and thus showed a similar expression pattern. Due to an unfortunate oversight, we cropped and presented ɑ-Tubulin twice. We here provide a corrected Supplementary Fig. 2b, replacing the erroneous panels with a new one from the original immunoblot, that now shows both ɑ-Tubulin (Cell Signaling, Cat. # 3873) and GAPDH (Cell Signaling, Cat. # 2118S) expression. Of note, the interpretation of the presented data is unchanged.

Supplementary information

Supplemental Material (6.4MB, pdf)

Contributor Information

Luca Giordano, Email: giordano@pitt.edu.

Marten Szibor, Email: Marten.Szibor@med.uni-jena.de.

Supplementary information

The online version contains supplementary material available at 10.1038/s41434-024-00473-x.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Material (6.4MB, pdf)

Articles from Gene Therapy are provided here courtesy of Nature Publishing Group

RESOURCES